In the context of DN, elevated GSK3β expression has been observed within glomeruli of patients with diabetes (12) and increased expression of GSK3β in urinary exfoliated renal cells from diabetic patients is a predictive biomarker of disease progression (7). Here, GSK3B is linked to diabetes mellitus.